Bitcoin's price discount in the US market has slightly narrowed since late October, indicating a modest easing in weak demand. Institutional trading volume on Coinbase Prime increased, suggesting more market participation, though the persistent discount and a larger short futures position show mixed signals. Market indicators like the VIX and dollar index also softened, reflecting a cautious improvement in buying conditions rather than strong conviction. Overall, data points to tentative improvement in US bitcoin demand amid ongoing uncertainty.
Bitcoin's US price discount and market participation provide context for cryptocurrency trends. For readers following crypto markets, here is Pluang's snapshot as of Nov 02, 2026 19:42 WIB: out of 50 major cryptocurrencies, 7 rose and 42 fell. Notable movers include SNX at Rp3.230 with a 1-day change of -3.32% and a typical hold time of 71 days, ENJ at Rp430 down 3.22% with 98% sell order activity, and GRT at Rp358 down 3.08% with a slight buy order majority of 55%.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
